SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-22-000088
Filing Date
2022-11-14
Accepted
2022-11-14 16:24:32
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20220930.htm   iXBRL 10-Q 1711652
2 EX-10.5 exhibit10520221011_restate.htm EX-10.5 128778
3 EX-31.1 exicureexhibit311-93022.htm EX-31.1 8024
4 EX-31.2 exicureexhibit312-93022.htm EX-31.2 7968
5 EX-32.1 exicureexhibit321-93022.htm EX-32.1 8313
  Complete submission text file 0001698530-22-000088.txt   7363236

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220930.xsd EX-101.SCH 47601
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20220930_cal.xml EX-101.CAL 65460
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20220930_def.xml EX-101.DEF 212194
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220930_lab.xml EX-101.LAB 614031
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220930_pre.xml EX-101.PRE 399060
75 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220930_htm.xml XML 1133065
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 221386077
SIC: 2834 Pharmaceutical Preparations